As per the terms of a settlement agreement with Abbott Labs and Fournier Laboratories, Impax...


As per the terms of a settlement agreement with Abbott Labs and Fournier Laboratories, Impax (IPXL) launches generic Trilipix. IPXL was granted the right to sell an authorized generic as early as July 15. Shares +0.3% AH.

From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs